SUD & Addiction Billing for Indiana Treatment Centers

Hand SUD billing off here for one blunt reason: Indiana addiction billing has too many moving parts for a clinical team to carry on the side. The Healthy Indiana Plan (HIP) and Medicaid managed-care entities each have their own authorization rules; DMHA governs ASAM level-of-care designation that determines what a facility may bill; commercial payers add out-of-network reimbursement, single-case agreements, and appeals; and utilization review, drug-testing compliance, and 42 CFR Part 2 sit on top of all of it. Every misrouted claim or missed review is margin an addiction program cannot spare. As a specialist billing services company we absorb that complexity so your clinicians and admissions team stop losing hours to authorization callbacks and payer holds.

The in-house math rarely favors staying in-house. An Indiana program spanning HIP managed Medicaid, commercial, and occasional out-of-network residential typically needs a biller, a UR coordinator, a credentialing hand, and billing software — a fixed cost that does not flex with census. A professional partner replaces that fixed overhead with a variable fee tied to what you actually collect, while adding depth an individual hire cannot: appeals specialists, payer-contract knowledge, and a compliance backbone. Our numbers are the ones that survive scrutiny: up to 40% fewer denials, roughly 90% of worked denials recovered, and 98% client retention.

That is the case to outsource your addiction-treatment revenue cycle to a partner built for SUD rather than carry the risk alone. Programs that also run general medical lines can consolidate them with the same Indiana medical billing services team.

Codes, revenue codes, and ASAM levels live here — in the table — never scattered through the prose. This is how the continuum converts to payment in Indiana.

Indiana's opioid response leans heavily on medication-assisted treatment, and each MAT pathway carries billing mechanics a generalist rarely handles well. Opioid treatment programs bill a weekly bundled payment that must reconcile dosing days, counseling, and drug testing into a single defensible unit, while office-based buprenorphine practices bill evaluation-and-management alongside medication management on an entirely different logic. Extended-release naltrexone adds its own drug-and-administration billing. When these are coded as if they were ordinary outpatient visits, revenue leaks quietly and audit exposure grows, so we bill each pathway to its own rules and keep medication access from becoming a billing casualty.

Drug testing demands the same discipline. Presumptive versus definitive urine drug testing is the most audited and most recouped area in SUD billing, and Indiana payers scrutinize frequency and medical necessity closely. We document the ordering rationale, reconcile every specimen back to an order, and code to each payer's limits so testing revenue holds up under review rather than turning into a recoupment. Paired with correct per-diem-versus-fee-for-service coding across the continuum and disciplined concurrent-review tracking, that closes the leak points that most often drain an Indiana program's collections — before a claim ever leaves the building.

Indiana addiction programs choose us because we already speak Healthy Indiana Plan managed Medicaid, DMHA ASAM designation, and out-of-network commercial in the same breath. We bill the entire ASAM continuum and reconcile every unit and per-diem day to the documentation an Indiana utilization reviewer will actually open — with first-pass clean-claim rates near 99%, days in A/R held under 25, and no multi-year lock-in.